Morrison FJ, Zhang H, Skentzos S, Shubina M, Bentley-Lewis R, Turchin A. Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease. Cardiorenal Med. 2014 Dec;4(3-4):225-33. doi: 10.1159/000368914. Epub 2014 Nov 19.
Gafencu M, Isac R, Costa R, Doroş G. Late onset of HIVAN in a young female – a case report. Rom J Morphol Embryol. 2014;55(4):1463-7.
Généreux P, Cohen DJ, Mack M, Rodes-Cabau J, Yadav M, Xu K, Parvataneni R, Hahn R, Kodali SK, Webb JG, Leon MB. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014 Dec 23;64(24):2605-2615. doi: 10.1016/j.jacc.2014.08.052.
Osborn EA, Cutlip DE. Do you see what I see? Time for a standardized approach to angiography-based decision making. Circ Cardiovasc Interv. 2014 Dec;7(6):736-8. doi: 10.1161/CIRCINTERVENTIONS.114.002082.
Carruthers TN, Farber A, Rybin D, Doros G, Eslami MH. Interventions on the superficial venous system for chronic venous insufficiency by surgeons in the modern era: an analysis of ACS-NSQIP. Vasc Endovascular Surg. 2014 Oct-Nov;48(7-8):482-90. doi: 10.1177/1538574414561226. Epub 2014 Dec 8.
Bainey KR, Ferguson C, Ibrahim QI, Tyrrell B, Welsh RC; Vital Heart Response Registry Investigators. Impact of reperfusion strategy on aborted myocardial infarction: insights from a large Canadian ST-Elevation Myocardial Infarction Clinical Registry. Can J Cardiol. 2014 Dec;30(12):1570-5. doi: 10.1016/j.cjca.2014.08.021. Epub 2014 Aug 27.
Seifarth H, Schlett CL, Lehman SJ, Bamberg F, Donnelly P, Januzzi JL, Koenig W, Truong QA, Hoffmann U. Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography. J Cardiovasc Comput Tomogr. 2014 Nov-Dec;8(6):452-8. doi: 10.1016/j.jcct.2014.09.005. Epub 2014 Sep 16.
Garcia-Banigan D, Guay A, Traish A, Doros G, Gawoski J. In women, no significant variances of calculated free testosterone (cFT) are observed when a fixed value of albumin (Alb: 4.3 g/dL) is used instead of measured albumin values. Horm Mol Biol Clin Investig. 2014 Dec;20(3):91-7. doi: 10.1515/hmbci-2014-0027.
Andersson C, Lyass A, Vasan RS, Massaro JM, D’Agostino RB Sr, Robins SJ. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. Am Heart J. 2014 Dec;168(6):878-83.e1. doi: 10.1016/j.ahj.2014.08.007. Epub 2014 Sep 16.
Eslami MH, Rybin D, Doros G, Farber A. Care of patients undergoing vascular surgery at safety net public hospitals is associated with higher cost but similar mortality to nonsafety net hospitals. J Vasc Surg. 2014 Dec;60(6):1627-34. doi: 10.1016/j.jvs.2014.08.055. Epub 2014 Oct 14.
Grundeken MJ, Lu H, Mehran R, Cutlip DE, Leon MB, Yeung A, Koch KT, Montalescot G, van Geuns RJ, Spaargaren R, Buchbinder M. APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction–rationale and design. Am Heart J. 2014 Nov;168(5):652-60. doi: 10.1016/j.ahj.2014.07.011. Epub 2014 Jul 24.
Stroescu R, Micle I, Bizerea T, Puiu M, Mărginean O, Doroş G. Metabolic monitoring of obese children born small for gestational age. Obes Res Clin Pract. 2014 Nov-Dec;8(6):e592-8. doi: 10.1016/j.orcp.2014.01.001. Epub 2014 Jan 29.
Alistar A, Chou JW, Nagalla S, Black MA, D’Agostino R Jr, Miller LD. Dual roles for immune metagenes in breast cancer prognosis and therapy prediction. Genome Med. 2014 Oct 28;6(10):80. doi: 10.1186/s13073-014-0080-8. eCollection 2014.
Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.
Waldo SW, Secemsky EA, O’Brien C, Kennedy KF, Pomerantsev E, Sundt TM 3rd, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23;130(25):2295-301. doi: 10.1161/CIRCULATIONAHA.114.011541. Epub 2014 Nov 12.
Reynolds MR, Apruzzese P, Galper BZ, Murphy TP, Hirsch AT, Cutlip DE, Mohler ER 3rd, Regensteiner JG, Cohen DJ. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. J Am Heart Assoc. 2014 Nov 11;3(6):e001233. doi: 10.1161/JAHA.114.001233.
Legrand M, De Berardinis B, Gaggin HK, Magrini L, Belcher A, Zancla B, Femia A, Simon M, Motiwala S, Sambhare R, Di Somma S, Mebazaa A, Vaidya VS, Januzzi JL Jr; Global Research on Acute Conditions Team (GREAT). Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One. 2014 Nov 11;9(11):e112313. doi: 10.1371/journal.pone.0112313. eCollection 2014.
Vardi M, Lei L, Shangguan S, Doros G. Variability in freedom from loss of primary patency results in trials assessing stent implantation in the superficial femoral artery. J Invasive Cardiol. 2014 Nov;26(11):614-7.
Yeh RW, Drachman DE. Culprit only, multivessel, or staged multivessel intervention in STEMI: new insights or insurmountable methodologic obstacles?. Catheter Cardiovasc Interv. 2014 Nov 15;84(6):923-4. doi: 10.1002/ccd.25673.
Zhang R, Zhang Y, Zhang J, An T, Huang Y, Guo X, Januzzi JL, Cappola TP, Yin S, Wang Y, Zhou Q, Zou C, Ji S, Lv R. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure. PLoS One. 2014 Oct 27;9(10):e110976. doi: 10.1371/journal.pone.0110976. eCollection 2014.
Mauri L, Galper BZ. Late stent thrombosis: can it be prevented?. JACC Cardiovasc Interv. 2014 Oct;7(10):1103-4. doi: 10.1016/j.jcin.2014.06.008.
Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL 2nd, Douglas PS, Svensson LG, Gada H, Thourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ; PARTNER Investigators. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv. 2014 Dec;7(6):829-36. doi: 10.1161/CIRCINTERVENTIONS.114.001395. Epub 2014 Oct 21.
Mays AC, Moustafa F, Worley M, Waltonen JD, D’Agostino R Jr. A model for predicting gastrostomy tube placement in patients undergoing surgery for upper aerodigestive tract lesions. JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1198-206. doi: 10.1001/jamaoto.2014.2360.
Turchin A, Sawarkar A, Dementieva YA, Breydo E, Ramelson H. Effect of EHR user interface changes on internal prescription discrepancies. Appl Clin Inform. 2014 Aug 6;5(3):708-20. doi: 10.4338/ACI-2014-03-RA-0023. eCollection 2014.
Gafencu M, Jurca-Simina IE, Costa R, Doros G. Distal renal tubular acidosis in AIDS young woman with wasting syndrome. Int Urol Nephrol. 2014 Dec;46(12):2423-7. doi: 10.1007/s11255-014-0840-9. Epub 2014 Oct 9.
Beohar N, Zajarias A, Thourani VH, Herrmann HC, Mack M, Kapadia S, Green P, Arnold SV, Cohen DJ, Généreux P, Xu K, Leon MB, Kirtane AJ. Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). Am J Cardiol. 2014 Nov 15;114(10):1550-5. doi: 10.1016/j.amjcard.2014.08.021. Epub 2014 Aug 27.
Pracon R, Opolski MP, Mintz GS, Pregowski J, Kruk M, Popma JJ, Mandinov L, Wang H, Ellis SG, Grube E, Dawkins KD, Stone GW, Weissman NJ. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. J Invasive Cardiol. 2014 Oct;26(10):501-11.
Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation. 2014 Nov 4;130(19):1676-83. doi: 10.1161/CIRCULATIONAHA.114.009273. Epub 2014 Oct 1.
De Marco M, D’Auria R, Rosati A, Vitulano G, Gigantino A, Citro R, Piscione F, Zilinski J, Januzzi JL Jr, Turco MC. BAG3 protein in advanced-stage heart failure. JACC Heart Fail. 2014 Dec;2(6):673-5. doi: 10.1016/j.jchf.2014.05.012. Epub 2014 Sep 24.
Gibson CM, Krucoff M, Kirtane AJ, Rao SV, Mackall JA, Matthews R, Saba S, Waksman R, Holmes D. Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. Am Heart J. 2014 Oct;168(4):424-429.e1. doi: 10.1016/j.ahj.2014.05.010. Epub 2014 Jun 2.
Sánchez-Martínez M, López-Cuenca A, Marín F, Flores-Blanco PJ, García Narbon A, de las Heras-Gómez I, Sánchez-Galian MJ, Valdés-Chávarri M, Januzzi JL, Manzano-Fernández S. Red cell distribution width and additive risk prediction for major bleeding in non-ST-segment elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2014 Oct;67(10):830-6. doi: 10.1016/j.rec.2013.12.018. Epub 2014 May 16.
Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Califf RM, Kouchoukos NT, Peterson ED, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014 Oct 21;130(17):1445-51. doi: 10.1161/CIRCULATIONAHA.113.008193. Epub 2014 Sep 26.
Popma JJ, Khabbaz K. Prosthesis-patient mismatch after “high-risk” aortic valve replacement. J Am Coll Cardiol. 2014 Sep 30;64(13):1335-8. doi: 10.1016/j.jacc.2014.07.952.
Di Mundo R, d’Agostino R, Palumbo F. Long-lasting antifog plasma modification of transparent plastics. ACS Appl Mater Interfaces. 2014 Oct 8;6(19):17059-66. doi: 10.1021/am504668s. Epub 2014 Sep 24.
Gandhi PU, Gaggin HK, Sheftel AD, Belcher AM, Weiner RB, Baggish AL, Motiwala SR, Liu PP, Januzzi JL Jr. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?. Am J Cardiol. 2014 Nov 15;114(10):1543-9. doi: 10.1016/j.amjcard.2014.08.018. Epub 2014 Aug 27.
Young MN, Yeh RW. Public reporting and coronary revascularization: risk and benefit. Coron Artery Dis. 2014 Nov;25(7):619-26. doi: 10.1097/MCA.0000000000000169.
Gopal DM, Larson MG, Januzzi JL, Cheng S, Ghorbani A, Wollert KC, Kempf T, D’Agostino RB, Polak JF, Ramachandran VS, Wang TJ, Ho JE. Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community. Clin Chem. 2014 Nov;60(11):1402-8. doi: 10.1373/clinchem.2014.227116. Epub 2014 Sep 18.
Stolker JM, Spertus JA, Cohen DJ, Jones PG, Jain KK, Bamberger E, Lonergan BB, Chan PS. Rethinking composite end points in clinical trials: insights from patients and trialists. Circulation. 2014 Oct 7;130(15):1254-61. doi: 10.1161/CIRCULATIONAHA.113.006588. Epub 2014 Sep 8.
Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Leifer ES, Mark DB, Desvigne-Nickens P, Paynter G, Piña IL, Whellan DJ, O’Connor CM. Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. JACC Heart Fail. 2014 Oct;2(5):457-65. doi: 10.1016/j.jchf.2014.05.007. Epub 2014 Sep 3.
Baron SJ, Yeh RW, Cohen DJ. The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes. Circulation. 2014 Oct 14;130(16):1343-5. doi: 10.1161/CIRCULATIONAHA.114.012640. Epub 2014 Sep 4.
Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 Sep 4;371(10):967-8. doi: 10.1056/NEJMc1408396.
Pencina KM, Pencina MJ, D’Agostino RB Sr. What to expect from net reclassification improvement with three categories. Stat Med. 2014 Dec 10;33(28):4975-87. doi: 10.1002/sim.6286. Epub 2014 Aug 31.
Dejam A, Malley BE, Feng M, Cismondi F, Park S, Samani S, Samani ZA, Pinto DS, Celi LA. The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients. Crit Care. 2014 Aug 30;18(4):487. doi: 10.1186/s13054-014-0487-z.
O’Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061.
Vodovar N, Séronde MF, Laribi S, Gayat E, Lassus J, Boukef R, Nouira S, Manivet P, Samuel JL, Logeart D, Ishihara S, Cohen Solal A, Januzzi JL Jr, Richards AM, Launay JM, Mebazaa A; GREAT Network. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J. 2014 Dec 21;35(48):3434-41. doi: 10.1093/eurheartj/ehu314. Epub 2014 Aug 24.
Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL 3rd, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ; CoreValve US Clinical Investigators. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2869-76.e1-7. doi: 10.1016/j.jtcvs.2014.07.020. Epub 2014 Jul 30.
Rassi AN, Pibarot P, Elmariah S. Left ventricular remodelling in aortic stenosis. Can J Cardiol. 2014 Sep;30(9):1004-11. doi: 10.1016/j.cjca.2014.04.026. Epub 2014 Apr 30.
Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, Jorgensen JP, Mazzaferri EL Jr, Jolly SS, Jacobs A, Newby LK, Gibson CM, Kong DF, Mehran R, Waksman R, Gilchrist IC, McCourt BJ, Messenger JC, Peterson ED, Harrington RA, Krucoff MW. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014 Aug;7(8):857-67. doi: 10.1016/j.jcin.2014.04.007.
Yeh RW, Wimmer NJ. Blood transfusion in myocardial infarction: opening old wounds for comparative-effectiveness research. J Am Coll Cardiol. 2014 Aug 26;64(8):820-2. doi: 10.1016/j.jacc.2014.05.041.
Bainey KR, O’Neill BJ. Revascularization strategies for coronary disease: art or science?. Can J Cardiol. 2014 Oct;30(10):1153-4. doi: 10.1016/j.cjca.2014.05.017. Epub 2014 May 29.
Tachjian A, Shafer KM, Denkinger C, Pinto DS. Purulent pericarditis after transbronchial biopsy. Can J Cardiol. 2014 Oct;30(10):1250.e19-21. doi: 10.1016/j.cjca.2014.04.013. Epub 2014 Apr 18.
Costa PE, Vasconcelos JB, Coelho GR, Barros MA, Neto BA, Pinto DS, Júnior JT, Correia FG, Garcia JH. Ten-year experience with liver transplantation for hepatocellular carcinoma in a Federal University Hospital in the Northeast of Brazil. Transplant Proc. 2014 Jul-Aug;46(6):1794-8. doi: 10.1016/j.transproceed.2014.05.016.
Reynolds MR. Outcomes with digoxin in atrial fibrillation: more data, no answers. J Am Coll Cardiol. 2014 Aug 19;64(7):669-71. doi: 10.1016/j.jacc.2014.04.070.
Greene JM, Weiler AM, Reynolds MR, Cain BT, Pham NH, Ericsen AJ, Peterson EJ, Crosno K, Brunner K, Friedrich TC, O’Connor DH. Rapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window. Retrovirology. 2014 Aug 14;11:66. doi: 10.1186/s12977-014-0066-z.
Wijns W, Steg PG, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Lipsic E, Alamgir F, Rademaker-Havinga T, Boersma E, Radke P, van Leeuwen F, Camenzind E; PROTECT Steering Committee and Investigators. Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial. Eur Heart J. 2014 Oct 21;35(40):2812-20. doi: 10.1093/eurheartj/ehu318. Epub 2014 Aug 8.
De Berardinis B, Magrini L, Zampini G, Zancla B, Salerno G, Cardelli P, Di Stasio E, Gaggin HK, Belcher A, Parry BA, Nagurney JT, Januzzi JL Jr, Di Somma S. Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure. Biomed Res Int. 2014;2014:983098. doi: 10.1155/2014/983098. Epub 2014 Jun 30.
Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
Haider A, Saad F, Doros G, Gooren L. Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study. Obes Res Clin Pract. 2014 Jul-Aug;8(4):e339-49. doi: 10.1016/j.orcp.2013.10.005. Epub 2013 Nov 5.
Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW; SYNTAX Trial Investigators. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
Hendricks NJ, Matsumoto AH, Angle JF, Baheti A, Sabri SS, Park AW, Stone JR, Patrie JT, Dworkin L, Cooper CJ, Murphy TP, Cutlip DE. Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates. Vasc Med. 2014 Oct;19(5):363-7. doi: 10.1177/1358863X14544715. Epub 2014 Jul 31.
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014 Sep 23;130(13):1037-43. doi: 10.1161/CIRCULATIONAHA.114.009081. Epub 2014 Jul 31.
Harskamp RE, Alexander JH, Schulte PJ, Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM, Kouchoukos NT, Harrington RA, Ferguson TB Jr, Lopes RD. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014 Aug;149(8):798-805. doi: 10.1001/jamasurg.2014.87.
Harrington RA, Popma CJ, Gibson CM. Advances in understanding percutaneous coronary intervention pharmacology: ischemia, bleeding, the ISAR research group, and a commitment to progress. Coron Artery Dis. 2014 Sep;25(6):453-5. doi: 10.1097/MCA.0000000000000137.
Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, Reist C, McCagg A, Braunwald E, Califf RM. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J. 2014 Aug;168(2):205-12.e1. doi: 10.1016/j.ahj.2014.05.004. Epub 2014 May 15.
Hess CN, Roe MT, Gibson CM, Temple RJ, Pencina MJ, Zarin DA, Anstrom KJ, Alexander JH, Sherman RE, Fiedorek FT, Mahaffey KW, Lee KL, Chow SC, Armstrong PW, Califf RM. Independent data monitoring committees: preparing a path for the future. Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15.
Guerchicoff A, Brener SJ, Maehara A, Witzenbichler B, Fahy M, Xu K, Gersh BJ, Mehran R, Gibson CM, Stone GW. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). JACC Cardiovasc Interv. 2014 Jul;7(7):733-40. doi: 10.1016/j.jcin.2014.01.166.
Leening MJ, Steyerberg EW, Van Calster B, D’Agostino RB Sr, Pencina MJ. Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective. Stat Med. 2014 Aug 30;33(19):3415-8. doi: 10.1002/sim.6133.
Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, Buxton AE, Josephson ME, Gelfand E, Manning WJ. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014 Nov;11(11):1890-7. doi: 10.1016/j.hrthm.2014.07.015. Epub 2014 Jul 14.
Xu S, Hua SY, Menton R, Barker K, Menon S, D’Agostino RB. Inference of equivalence for the ratio of two normal means with unspecified variances. J Biopharm Stat. 2014;24(6):1264-79. doi: 10.1080/10543406.2014.941990.
Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S724-31. doi: 10.1007/s11606-014-2910-1.
Eijsvogels TM, Januzzi JL, Taylor BA, Isaacs SK, D’Hemecourt P, Zaleski A, Dyer S, Troyanos C, Weiner RB, Thompson PD, Baggish AL. Impact of statin use on exercise-induced cardiac troponin elevations. Am J Cardiol. 2014 Aug 15;114(4):624-8. doi: 10.1016/j.amjcard.2014.05.047. Epub 2014 Jun 6.
Truong QA, Januzzi JL, Szymonifka J, Thai WE, Wai B, Lavender Z, Sharma U, Sandoval RM, Grunau ZS, Basnet S, Babatunde A, Ajijola OA, Min JK, Singh JP. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study. Heart Rhythm. 2014 Dec;11(12):2167-75. doi: 10.1016/j.hrthm.2014.07.007. Epub 2014 Jul 8.
Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014 Jul 15;64(2):172-81. doi: 10.1016/j.jacc.2013.12.062.
Rutter MK, Sullivan LM, Fox CS, Wilson PW, Nathan DM, Vasan RS, D’Agostino RB Sr, Meigs JB. Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. Metab Syndr Relat Disord. 2014 Sep;12(7):372-80. doi: 10.1089/met.2013.0148. Epub 2014 Jul 9.
Wallentin L, Becker RC, Cannon CP, Held C, Himmelmann A, Husted S, James SK, Katus HA, Mahaffey KM, Pieper KS, Storey RF, Steg PG, Harrington RA; PLATO Investigators. No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014. Int J Cardiol. 2014 Sep;176(1):300-2. doi: 10.1016/j.ijcard.2014.06.029. Epub 2014 Jun 27.
Gadey G, Reynolds MR. Cost-effectiveness considerations in transcatheter management of valvular heart disease. Can J Cardiol. 2014 Sep;30(9):1058-63. doi: 10.1016/j.cjca.2014.03.005. Epub 2014 Mar 12.
Vatca M, Lucas JT Jr, Laudadio J, D’Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, Porosnicu M. Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Oral Oncol. 2014 Sep;50(9):869-76. doi: 10.1016/j.oraloncology.2014.06.010. Epub 2014 Jul 3.
Vardi M, Perez J, Griffin PJ, Burke DA, Yeh RW, Cutlip DE. Usefulness of postmarket studies to evaluate long-term safety of coronary eluting stents (from the ENDEAVOR and PROTECT Programs). Am J Cardiol. 2014 Aug 15;114(4):528-33. doi: 10.1016/j.amjcard.2014.05.028. Epub 2014 Jun 6.
Krygier JE, Lewis VO, Cannon CP, Satcher RL, Moon BS, Lin PP. Operative management of metastatic melanoma in bone may require en bloc resection of disease. Clin Orthop Relat Res. 2014 Oct;472(10):3196-203. doi: 10.1007/s11999-014-3761-0. Epub 2014 Jul 3.
Richards AM, Januzzi JL Jr, Troughton RW. Natriuretic peptides in heart failure with preserved ejection fraction. Heart Fail Clin. 2014 Jul;10(3):453-70. doi: 10.1016/j.hfc.2014.04.006. Epub 2014 May 22.
McCabe JM, Kennedy KF, Yeh RW. Defining unavoidable delays in primary percutaneous coronary intervention: discordance among patients excluded from National Cardiovascular Quality Registries. J Am Heart Assoc. 2014 Jun 25;3(3):e000944. doi: 10.1161/JAHA.114.000944.
Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, Zajarias A, Thourani VH, Green P, Rodés-Cabau J, Beohar N, Mack MJ, Leon MB, Cohen DJ; PARTNER Investigators. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014 Jun 24;129(25):2682-90. doi: 10.1161/CIRCULATIONAHA.113.007477. Epub 2014 May 23.
Varenhorst C, Alström U, Braun OÖ, Storey RF, Mahaffey KW, Bertilsson M, Cannon CP, Scirica BM, Himmelmann A, James SK, Wallentin L, Held C. Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes. Heart. 2014 Nov;100(22):1762-9. doi: 10.1136/heartjnl-2014-305619. Epub 2014 Jun 23.
Charytan DM, Reynolds MR. Do implantable defibrillators help patients with CKD?. Am J Kidney Dis. 2014 Jul;64(1):4-6. doi: 10.1053/j.ajkd.2014.04.007.
Wimmer NJ, Cohen DJ, Wasfy JH, Rathore SS, Mauri L, Yeh RW. Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?. Am Heart J. 2014 Jul;168(1):103-9. doi: 10.1016/j.ahj.2014.02.013. Epub 2014 Apr 4.
Marino M, Li Y, Pencina MJ, D’Agostino RB Sr, Berkman LF, Buxton OM. Quantifying cardiometabolic risk using modifiable non-self-reported risk factors. Am J Prev Med. 2014 Aug;47(2):131-40. doi: 10.1016/j.amepre.2014.03.006. Epub 2014 Jun 17.
Voigt J, Sasha John M, Taylor A, Krucoff M, Reynolds MR, Michael Gibson C. A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol. 2014 May;37(5):312-21. doi: 10.1002/clc.22260.
Strom JB, Wimmer NJ, Wasfy JH, Kennedy K, Yeh RW. Association between operator procedure volume and patient outcomes in percutaneous coronary intervention: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):560-6. doi: 10.1161/CIRCOUTCOMES.114.000884. Epub 2014 Jun 17.
Wimmer NJ, Spertus JA, Kennedy KF, Anderson HV, Curtis JP, Weintraub WS, Singh M, Rumsfeld JS, Masoudi FA, Yeh RW. Clinical prediction model suitable for assessing hospital quality for patients undergoing carotid endarterectomy. J Am Heart Assoc. 2014 Jun 17;3(3):e000728. doi: 10.1161/JAHA.113.000728.
Turer AT, Lewis GD, O’Sullivan JF, Elmariah S, Mega JL, Addo TA, Sabatine MS, de Lemos JA, Gerszten RE. Increases in myocardial workload induced by rapid atrial pacing trigger alterations in global metabolism. PLoS One. 2014 Jun 16;9(6):e99058. doi: 10.1371/journal.pone.0099058. eCollection 2014.
Ahmad T, Fiuzat M, Pencina MJ, Geller NL, Zannad F, Cleland JG, Snider JV, Blankenberg S, Adams KF, Redberg RF, Kim JB, Mascette A, Mentz RJ, O’Connor CM, Felker GM, Januzzi JL. Charting a roadmap for heart failure biomarker studies. JACC Heart Fail. 2014 Oct;2(5):477-88. doi: 10.1016/j.jchf.2014.02.005. Epub 2014 Jun 11.
Kaila KS, Norris CM, Graham MM, Ali I, Bainey KR. Long-term survival with revascularization in South Asians admitted with an acute coronary syndrome (from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease Registry). Am J Cardiol. 2014 Aug 1;114(3):395-400. doi: 10.1016/j.amjcard.2014.04.051. Epub 2014 May 16.
Zhang H, Plutzky J, Turchin A. (Mis)interpreting studies on the adverse effects of statins. BMJ. 2014 Jun 11;348:g3652. doi: 10.1136/bmj.g3652.
Chrysant GS, Bates MC, Sullivan TM, Bachinsky WB, Popma JJ, Peng L, Omran HL, Jaff MR; HERCULES Investigators. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J Clin Hypertens (Greenwich). 2014 Jul;16(7):497-503. doi: 10.1111/jch.12341. Epub 2014 Jun 7.
Evans KL, Tuttle KR, Folt DA, Dawson T, Haller ST, Brewster PS, He W, Jamerson K, Dworkin LD, Cutlip DE, Murphy TP, D’Agostino RB Sr, Henrich W, Cooper CJ. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol. 2014 Jul;9(7):1199-206. doi: 10.2215/CJN.11611113. Epub 2014 Jun 5.
Manchette AM, Drucker AG, Januzzi JL Jr. Acute coronary syndrome antiplatelet alternatives in clopidogrel allergy. Pharmacotherapy. 2014 Aug;34(8):e152-6. doi: 10.1002/phar.1446. Epub 2014 Jun 5.
Potter BJ, Yeh RW, Pinto DS. Public reporting of PCI outcomes: for better or for worse. Curr Cardiol Rep. 2014 Jul;16(7):500. doi: 10.1007/s11886-014-0500-9.
Potter BJ, Pinto DS. Subclavian steal syndrome. Circulation. 2014 Jun 3;129(22):2320-3. doi: 10.1161/CIRCULATIONAHA.113.006653.
Meijers WC, Januzzi JL, deFilippi C, Adourian AS, Shah SJ, van Veldhuisen DJ, de Boer RA. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. Am Heart J. 2014 Jun;167(6):853-60.e4. doi: 10.1016/j.ahj.2014.02.011. Epub 2014 Mar 5.
Kaufman LB, Setiono TK, Doros G, Andersen S, Silliman RA, Friedman PK, Perls TT. An oral health study of centenarians and children of centenarians. J Am Geriatr Soc. 2014 Jun;62(6):1168-73. doi: 10.1111/jgs.12842. Epub 2014 Jun 2.
Bainey KR, Armstrong PW. Ameliorating reperfusion injury in STEMI: dead or alive?. Eur Heart J. 2014 Oct 1;35(37):2504-6. doi: 10.1093/eurheartj/ehu200. Epub 2014 May 29.
Gibson CM, Pass SE. Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit. J Crit Care. 2014 Oct;29(5):803-7. doi: 10.1016/j.jcrc.2014.04.005. Epub 2014 Apr 18.
Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O’Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20.
Kaufman AS, Zhou X, Reynolds MR, Kaufman NL, Green GP, Weiss LG. The possible societal impact of the decrease in U.S. blood lead levels on adult IQ. Environ Res. 2014 Jul;132:413-20. doi: 10.1016/j.envres.2014.04.015. Epub 2014 May 21.
Januzzi JL Jr, Hauptman PJ. Reversed reverse remodeling: can biomonitoring solve the clinical conundrum of the 3Rs?. Circ Heart Fail. 2014 May;7(3):388-90. doi: 10.1161/CIRCHEARTFAILURE.114.001357.
Kerfoot BP, Turchin A, Breydo E, Gagnon D, Conlin PR. An online spaced-education game among clinicians improves their patients’ time to blood pressure control: a randomized controlled trial. Circ Cardiovasc Qual Outcomes. 2014 May;7(3):468-74. doi: 10.1161/CIRCOUTCOMES.113.000814.
Samy B, Soeda T, Januzzi JL, Gaggin HK, Jang IK. Different vascular responses within the same stent detected by optical coherence tomography. Coron Artery Dis. 2014 Aug;25(5):450-1. doi: 10.1097/MCA.0000000000000125.
Choksy P, Davis HC, Januzzi J, Thayer J, Harshfield G, Robinson VJ, Kapuku GK. Brain natriuretic hormone predicts stress-induced alterations in diastolic function. Am J Med Sci. 2014 Nov;348(5):366-70. doi: 10.1097/MAJ.0000000000000261.
Sánchez-Más J, Lax A, Asensio-López Mdel C, Fernandez-Del Palacio MJ, Caballero L, Santarelli G, Januzzi JL, Pascual-Figal DA. Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers. Eur J Clin Invest. 2014 Jul;44(7):643-51. doi: 10.1111/eci.12282.
Sankoh AJ, Li H, D’Agostino RB Sr. Use of composite endpoints in clinical trials. Stat Med. 2014 Nov 30;33(27):4709-14. doi: 10.1002/sim.6205. Epub 2014 May 15.
Legrand M, Mebazaa A, Ronco C, Januzzi JL Jr. When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome. Crit Care Med. 2014 Sep;42(9):2109-17. doi: 10.1097/CCM.0000000000000404.
Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Eur Heart J. 2014 Oct 14;35(39):2706-13. doi: 10.1093/eurheartj/ehu154. Epub 2014 May 8.
Tan TW, Rybin D, Doros G, Kalish JA, Farber A, Eslami MH. Observation and surgery are associated with low risk of amputation for blunt brachial artery injury in pediatric patients. J Vasc Surg. 2014 Aug;60(2):443-7. doi: 10.1016/j.jvs.2014.02.054. Epub 2014 May 5.
Gibson CM, Penn DL, Smedley KL, Leserman J, Elliott T, Pedersen CA. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia. Schizophr Res. 2014 Jul;156(2-3):261-5. doi: 10.1016/j.schres.2014.04.009. Epub 2014 May 3.
Czarny MJ, Nathan AS, Yeh RW, Mauri L. Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 2014 Aug;37(8):505-13. doi: 10.1002/clc.22289. Epub 2014 May 2.
Gordon LB, Massaro J, D’Agostino RB Sr, Campbell SE, Brazier J, Brown WT, Kleinman ME, Kieran MW; Progeria Clinical Trials Collaborative. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014 Jul 1;130(1):27-34. doi: 10.1161/CIRCULATIONAHA.113.008285. Epub 2014 May 2.
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014 Jun 15;113(12):2052-6. doi: 10.1016/j.amjcard.2014.03.049. Epub 2014 Apr 1.
Selker HP, Udelson JE, Massaro JM, Ruthazer R, D’Agostino RB, Griffith JL, Sheehan PR, Desvigne-Nickens P, Rosenberg Y, Tian X, Vickery EM, Atkins JM, Aufderheide TP, Sayah AJ, Pirrallo RG, Levy MK, Richards ME, Braude DA, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Beshansky JR. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial). Am J Cardiol. 2014 May 15;113(10):1599-605. doi: 10.1016/j.amjcard.2014.02.010. Epub 2014 Mar 1.
Sarma A, Cannon CP, de Lemos J, Rouleau JL, Lewis EF, Guo J, Mega JL, Sabatine MS, O’Donoghue ML. The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome. J Am Heart Assoc. 2014 May 1;3(3):e000784. doi: 10.1161/JAHA.114.000784.
Edwards FH, Shahian DM, Grau-Sepulveda MV, Grover FL, Mayer JE, O’Brien SM, DeLong E, Peterson ED, McKay C, Shaw RE, Garratt KN, Dangas GD, Messenger J, Klein LW, Popma JJ, Weintraub WS. Composite outcomes in coronary bypass surgery versus percutaneous intervention. Ann Thorac Surg. 2014 Jun;97(6):1983-8; discussion 1988-90. doi: 10.1016/j.athoracsur.2014.01.087. Epub 2014 Apr 26.
Bainey KR, Armstrong PW. Clinical perspectives on reperfusion injury in acute myocardial infarction. Am Heart J. 2014 May;167(5):637-45. doi: 10.1016/j.ahj.2014.01.015. Epub 2014 Feb 26.
D’Agostino RB Sr, Ansell BJ, Mora S, Krumholz HM. Clinical decisions. The guidelines battle on starting statins. N Engl J Med. 2014 Apr 24;370(17):1652-8. doi: 10.1056/NEJMclde1314766.
Laird JR, Jain A, Zeller T, Feldman R, Scheinert D, Popma JJ, Armstrong EJ, Jaff MR; Complete SE Investigators. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial. J Endovasc Ther. 2014 Apr;21(2):202-12. doi: 10.1583/13-4548R.1.
Gabriel A, Donnelly J, Kuc A, Good D, Doros G, Matusz P, Loukas M. Ectopia cordis: a rare congenital anomaly. Clin Anat. 2014 Nov;27(8):1193-9. doi: 10.1002/ca.22402. Epub 2014 Apr 19.
Klein AJ, Pinto DS, Gray BH, Jaff MR, White CJ, Drachman DE; Peripheral Vascular Disease Committee for the Society for Cardiovascular Angiography and Interventions. SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014 Oct 1;84(4):529-38. doi: 10.1002/ccd.25504. Epub 2014 Jun 12.
Haider A, Yassin A, Doros G, Saad F. Effects of long-term testosterone therapy on patients with “diabesity”: results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes. Int J Endocrinol. 2014;2014:683515. doi: 10.1155/2014/683515. Epub 2014 Mar 11.
Gotto AM Jr, Kher U, Chatterjee MS, Liu Y, Li XS, Vaidya S, Cannon CP, Brinton EA, Moon JE, Shah S, Dansky HM, Mitchel Y, Barter P; DEFINE Investigators. Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study. J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):543-9. doi: 10.1177/1074248414529621. Epub 2014 Apr 14.
Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circ Cardiovasc Interv. 2014 Jun;7(3):365-73. doi: 10.1161/CIRCINTERVENTIONS.113.001126. Epub 2014 Apr 15.
Huffman JC, Mastromauro CA, Beach SR, Celano CM, DuBois CM, Healy BC, Suarez L, Rollman BL, Januzzi JL. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med. 2014 Jun;174(6):927-35. doi: 10.1001/jamainternmed.2014.739.
Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, Stevens SR, Wallentin L, James SK. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014 Aug 14;35(31):2083-93. doi: 10.1093/eurheartj/ehu160. Epub 2014 Apr 11.
Kim CA, Rasania SP, Afilalo J, Popma JJ, Lipsitz LA, Kim DH. Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med. 2014 Feb 18;160(4):243-54. doi: 10.7326/M13-1316.
Tan TW, Rybin D, Kalish JA, Doros G, Hamburg N, Schanzer A, Cronenwett JL, Farber A; Vascular Study Group of New England. Routine use of completion imaging after infrainguinal bypass is not associated with higher bypass graft patency. J Vasc Surg. 2014 Sep;60(3):678-85.e2. doi: 10.1016/j.jvs.2014.03.004. Epub 2014 Apr 8.
Xanthakis V, Sullivan LM, Vasan RS, Benjamin EJ, Massaro JM, D’Agostino RB Sr, Pencina MJ. Assessing the incremental predictive performance of novel biomarkers over standard predictors. Stat Med. 2014 Jul 10;33(15):2577-84. doi: 10.1002/sim.6165. Epub 2014 Apr 9.
Yassin DJ, Doros G, Hammerer PG, Yassin AA. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014 Jun;11(6):1567-76. doi: 10.1111/jsm.12523. Epub 2014 Apr 8.
Bainey KR, Gafni A, Rao-Melacini P, Tong W, Steg PG, Faxon DP, Lamy A, Granger CB, Yusuf S, Mehta SR; TIMACS Investigators. The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study. J Med Econ. 2014 Jun;17(6):415-22. doi: 10.3111/13696998.2014.911184. Epub 2014 Apr 16.
Lin DC, Diamandis EP, Januzzi JL Jr, Maisel A, Jaffe AS, Clerico A. Natriuretic peptides in heart failure. Clin Chem. 2014 Aug;60(8):1040-6. doi: 10.1373/clinchem.2014.223057. Epub 2014 Apr 3.
Haider A, Meergans U, Traish A, Saad F, Doros G, Lips P, Gooren L. Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years. Int J Endocrinol. 2014;2014:496948. doi: 10.1155/2014/496948. Epub 2014 Feb 13.
Shah AS, Dabelea D, Talton JW, Urbina EM, D Agostino RB Jr, Wadwa RP, Marcovina S, Hamman RF, Daniels SR, Dolan LM. Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study. J Pediatr. 2014 Jul;165(1):110-6. doi: 10.1016/j.jpeds.2014.02.024. Epub 2014 Mar 27.
Yeh RW, Wimmer NJ. Reply: Bleeding after PCI, vascular access, and falsification endpoints in observational studies. J Am Coll Cardiol. 2014 Jun 17;63(23):2587-2588. doi: 10.1016/j.jacc.2014.02.570. Epub 2014 Mar 26.
STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.
Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.
Vardi M, Debidda M, Bhatt DL, Mauri L, Cannon CP. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists. Clin Cardiol. 2014 Feb;37(2):103-7. doi: 10.1002/clc.22226.
McNulty EJ, Hung YY, Almers LM, Go AS, Yeh RW. Population trends from 2000-2011 in nuclear myocardial perfusion imaging use. JAMA. 2014 Mar 26;311(12):1248-9. doi: 10.1001/jama.2014.472.
Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njølstad I, Nissinen A, Brunner EJ, Kuller LH, Price JF, Sundström J, Knuiman MW, Feskens EJ, Verschuren WM, Wald N, Bakker SJ, Whincup PH, Ford I, Goldbourt U, Gómez-de-la-Cámara A, Gallacher J, Simons LA, Rosengren A, Sutherland SE, Björkelund C, Blazer DG, Wassertheil-Smoller S, Onat A, Marín Ibañez A, Casiglia E, Jukema JW, Simpson LM, Giampaoli S, Nordestgaard BG, Selmer R, Wennberg P, Kauhanen J, Salonen JT, Dankner R, Barrett-Connor E, Kavousi M, Gudnason V, Evans D, Wallace RB, Cushman M, D’Agostino RB Sr, Umans JG, Kiyohara Y, Nakagawa H, Sato S, Gillum RF, Folsom AR, van der Schouw YT, Moons KG, Griffin SJ, Sattar N, Wareham NJ, Selvin E, Thompson SG, Danesh J. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014 Mar 26;311(12):1225-33. doi: 10.1001/jama.2014.1873.
Azzalini L, Ghoshhajra BB, Elmariah S, Passeri JJ, Inglessis I, Palacios IF, Abbara S. The aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2014 Mar-Apr;8(2):131-40. doi: 10.1016/j.jcct.2013.12.013. Epub 2014 Jan 11.
Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19.
Andrews EB, Thomas J, Jaacks L, D’Agostino R Jr, Ward D, Mayer-Davis EJ. Patient Perception of Midlevel Providers in Pediatric Diabetes Care. Diabetes Educ. 2014 May;40(3):329-335. doi: 10.1177/0145721714527519. Epub 2014 Mar 20.
Pencina MJ, Navar-Boggan AM, D’Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014 Apr 10;370(15):1422-31. doi: 10.1056/NEJMoa1315665. Epub 2014 Mar 19.
Brener SJ, Oldroyd KG, Maehara A, El-Omar M, Witzenbichler B, Xu K, Mehran R, Gibson CM, Stone GW. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). Am J Cardiol. 2014 May 1;113(9):1457-60. doi: 10.1016/j.amjcard.2014.02.002. Epub 2014 Feb 12.
Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG; PROTECT Steering Committee and Investigators. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084. Epub 2014 Mar 13.
Gaggin HK, Szymonifka J, Bhardwaj A, Belcher A, De Berardinis B, Motiwala S, Wang TJ, Januzzi JL Jr. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. JACC Heart Fail. 2014 Feb;2(1):65-72. doi: 10.1016/j.jchf.2013.10.005. Epub 2014 Jan 25.
Baron JM, Lewandrowski EL, Januzzi JL, Bajwa EK, Thompson BT, Lewandrowski KB. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol. 2014 Apr;141(4):488-93. doi: 10.1309/AJCPLVQQY35XTFVN.
Fowler PW, Gibson CM, Bean DE. Writing with ring currents: selectively hydrogenated polycyclic aromatics as finite models of graphene and graphane. Proc Math Phys Eng Sci. 2014 Mar 8;470(2163):20130617. doi: 10.1098/rspa.2013.0617.
Kunadian V, Giugliano RP, Newby LK, Zorkun C, Guo J, Bagai A, Montalescot G, Braunwald E, Califf RM, Van de Werf F, Armstrong PW, Harrington R, Gibson CM. Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial). Am J Cardiol. 2014 Apr 15;113(8):1297-305. doi: 10.1016/j.amjcard.2014.01.404. Epub 2014 Jan 31.
Troughton RW, Frampton CM, Brunner-La Rocca HP, Pfisterer M, Eurlings LW, Erntell H, Persson H, O’Connor CM, Moertl D, Karlström P, Dahlström U, Gaggin HK, Januzzi JL, Berger R, Richards AM, Pinto YM, Nicholls MG. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J. 2014 Jun 14;35(23):1559-67. doi: 10.1093/eurheartj/ehu090. Epub 2014 Mar 6.
D’Agostino RB Sr, Collins SH, Pencina KM, Kean Y, Gorbach S. Risk estimation for recurrent Clostridium difficile infection based on clinical factors. Clin Infect Dis. 2014 May;58(10):1386-93. doi: 10.1093/cid/ciu107. Epub 2014 Mar 5.
Cavender MA, Rassi AN, Schwamm LH, Fonarow GC, Cannon CP, Peacock WF, Laskey WK, Hernandez AF, Peterson ED, Cox M, Grau-Sepulveda M, Bhatt DL. Response to Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: Findings from Get With the Guidelines-Coronary Artery Diseases. Authors’ reply. Clin Cardiol. 2014 May;37(5):323. doi: 10.1002/clc.22265. Epub 2014 Mar 4.
Xian Y, Chen AY, Thomas L, Roe MT, Subherwal S, Cannon CP, Pollack CV Jr, Fonarow GC, Kosiborod M, Peterson ED, Alexander KP. Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR). Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):236-43. doi: 10.1161/CIRCOUTCOMES.113.000715. Epub 2014 Mar 4.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL; REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014 Nov 1;35(41):2864-72. doi: 10.1093/eurheartj/ehu080. Epub 2014 Feb 28.
Azzalini L, Sharma UC, Ghoshhajra BB, Elmariah S, Inglessis I, Palacios IF, Abbara S. Feasibility of C-arm computed tomography for transcatheter aortic valve replacement planning. J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):33-43. doi: 10.1016/j.jcct.2013.12.001. Epub 2014 Jan 8.
Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Kitt MM, Lorenz TJ. The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. Am Heart J. 2014 Mar;167(3):335-41. doi: 10.1016/j.ahj.2013.11.006. Epub 2013 Dec 10.
Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Zhao X, Schwamm LH, Bhatt DL. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program. Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):227-35. doi: 10.1161/CIRCOUTCOMES.113.000422. Epub 2014 Feb 25.
Gaggin HK, Dang PV, Do LD, deFilippi CR, Christenson RH, Lewandrowski EL, Lewandrowski KB, Truong BQ, Pham VQ, Vu VH, Vu TV, Nguyen TB, Belcher AM, Femia A, Kelley C, Januzzi JL. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial. Clin Chem. 2014 May;60(5):758-64. doi: 10.1373/clinchem.2013.216275. Epub 2014 Feb 25.
Dizon JM, Brener SJ, Maehara A, Witzenbichler B, Biviano A, Godlewski J, Parise H, Dambrink JH, Mehran R, Gibson CM, Stone GW. Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):78-83. doi: 10.1177/2048872613508658. Epub 2013 Oct 3.
De Ferrari GM, Fox KA, White JA, Giugliano RP, Tricoci P, Reynolds HR, Hochman JS, Gibson CM, Théroux P, Harrington RA, Van de Werf F, White HD, Califf RM, Newby LK. Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):37-45. doi: 10.1177/2048872613489315. Epub 2013 May 9.
Brener SJ, Dambrink JH, Maehara A, Chowdhary S, Gershlick AH, Genereux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone GW. Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. EuroIntervention. 2014 Feb;9(10):1195-201. doi: 10.4244/EIJV9I10A201.
Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014 Apr 22;63(15):1522-8. doi: 10.1016/j.jacc.2014.01.036. Epub 2014 Feb 19.
Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2014 Apr 22;63(15):1493-9. doi: 10.1016/j.jacc.2014.01.038. Epub 2014 Feb 19.
Dangas GD, Kini AS, Sharma SK, Henriques JP, Claessen BE, Dixon SR, Massaro JM, Palacios I, Popma JJ, Ohman M, Stone GW, O’Neill WW. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014 Jan 15;113(2):222-8. doi: 10.1016/j.amjcard.2013.09.008.
Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb;11(2):216-21. doi: 10.1016/j.hrthm.2013.10.046.
Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM. PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187. Epub 2014 Feb 7.
Grobben RB, Nathoe HM, Januzzi JL Jr, van Kimmenade RR. Cardiac markers following cardiac surgery and percutaneous coronary intervention. Clin Lab Med. 2014 Mar;34(1):99-111, vii. doi: 10.1016/j.cll.2013.11.013.
Shah RV, Januzzi JL Jr. Soluble ST2 and galectin-3 in heart failure. Clin Lab Med. 2014 Mar;34(1):87-97, vi-vii. doi: 10.1016/j.cll.2013.11.009. Epub 2014 Jan 14.
Gaggin HK, Januzzi JL Jr. Natriuretic peptides in heart failure and acute coronary syndrome. Clin Lab Med. 2014 Mar;34(1):43-58, vi. doi: 10.1016/j.cll.2013.11.007. Epub 2014 Jan 14.
Rassi AN, Yeh RW. Cardiovascular event risk after noncardiac surgery. JAMA. 2014 Feb 5;311(5):525. doi: 10.1001/jama.2013.285279.
Chakrabarti AK, Grau-Sepulveda MV, O’Brien S, Abueg C, Ponirakis A, Delong E, Peterson E, Klein LW, Garratt KN, Weintraub WS, Gibson CM. Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study. Circ Cardiovasc Interv. 2014 Feb;7(1):11-8. doi: 10.1161/CIRCINTERVENTIONS.113.000679. Epub 2014 Feb 4.
Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG. Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada. Clinicoecon Outcomes Res. 2014 Jan 24;6:49-62. doi: 10.2147/CEOR.S51052. eCollection 2014.
Wang TY, McCoy L, Henry TD, Effron MB, Messenger JC, Cohen DJ, Mark DB, Stone GW, Zettler M, Singh M, Fonarow GC, Peterson ED; TRANSLATE-ACS Study Investigators. Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. J Am Coll Cardiol. 2014 Apr 29;63(16):1700-2. doi: 10.1016/j.jacc.2013.12.012. Epub 2014 Jan 30.
Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S; NXT Trial Study Group. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155. doi: 10.1016/j.jacc.2013.11.043. Epub 2014 Jan 30.
Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort. Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.
Rhee JW, Wiviott SD, Scirica BM, Gibson CM, Murphy SA, Bonaca MP, Morrow DA, Mega JL. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin Cardiol. 2014 Jun;37(6):350-6. doi: 10.1002/clc.22253. Epub 2014 Jan 30.
Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW; American Heart Association Stroke Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Mar;45(3):918-44. doi: 10.1161/01.str.0000441948.35804.77. Epub 2014 Jan 23.
Thukkani AK, Fonarow GC, Cannon CP, Cox M, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Schwamm LH, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD. Clin Cardiol. 2014 May;37(5):285-92. doi: 10.1002/clc.22246. Epub 2014 Jan 22.
Waks JW, Sabatine MS, Cannon CP, Morrow DA, Gibson CM, Wiviott SD, Giugliano RP, Sloan S, Scirica BM. Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial. Clin Cardiol. 2014 Mar;37(3):160-6. doi: 10.1002/clc.22235. Epub 2014 Jan 22.
Alman AC, Talton JW, Wadwa RP, Urbina EM, Dolan LM, Daniels SR, Hamman RF, D’Agostino RB, Marcovina SM, Mayer-Davis EJ, Dabelea DM. Cardiovascular health in adolescents with type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2014 Nov;15(7):502-10. doi: 10.1111/pedi.12120. Epub 2014 Jan 22.
Giri J, Kennedy KF, Weinberg I, Hawkins BM, Press MC, Drachman D, McCormick DJ, Aronow HD, White CJ, Rosenfield K, Yeh RW. Comparative effectiveness of commonly used devices for carotid artery stenting: an NCDR Analysis (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2014 Feb;7(2):171-177. doi: 10.1016/j.jcin.2013.10.014. Epub 2014 Jan 15.
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor F, Januzzi JL, Pascual-Figal DA. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172(1):e98-e101. doi: 10.1016/j.ijcard.2013.12.129. Epub 2014 Jan 4.
Vardi M, Piazza G, Pencina MJ, Burke DA, Lei L, Goldhaber SZ, Cutlip DE. Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2014 Jul;20(5):478-83. doi: 10.1177/1076029613517166. Epub 2014 Jan 14.
Hawkins BM, Fitzgerald-McKeon LM, Yeh RW. High-risk percutaneous coronary intervention in the era of public reporting: clinical and ethical considerations in the care of an elderly patient with critical left main disease and shock. Circulation. 2014 Jan 14;129(2):258-65. doi: 10.1161/CIRCULATIONAHA.113.004604.
Marrugat J, Subirana I, Ramos R, Vila J, Marín-Ibañez A, Guembe MJ, Rigo F, Tormo Díaz MJ, Moreno-Iribas C, Cabré JJ, Segura A, Baena-Díez JM, de la Cámara AG, Lapetra J, Grau M, Quesada M, Medrano MJ, González Diego P, Frontera G, Gavrila D, Aicua EA, Basora J, García JM, García-Lareo M, Gutierrez JA, Mayoral E, Sala J, D’Agostino R, Elosua R; FRESCO Investigators. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study. Prev Med. 2014 Apr;61:66-74. doi: 10.1016/j.ypmed.2013.12.031. Epub 2014 Jan 9.
Stefanescu A, Macklin EA, Lin E, Dudzinski DM, Johnson J, Kennedy KF, Jacoby D, DeFaria Yeh D, Lewis GD, Yeh RW, Liberthson R, Lui G, Bhatt AB. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. Am J Cardiol. 2014 Mar 1;113(5):865-70. doi: 10.1016/j.amjcard.2013.11.043. Epub 2013 Dec 12.
Xu S, Hua SY, Menton R, Barker K, Menon S, D’Agostino RB. Inference of bioequivalence for log-normal distributed data with unspecified variances. Stat Med. 2014 Jul 30;33(17):2924-38. doi: 10.1002/sim.6081. Epub 2014 Jan 9.
Toh S, Avorn J, D’Agostino RB Sr, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL. RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):109-10. doi: 10.1002/pds.3525.
Reynolds MR, Lamotte M, Todd D, Khaykin Y, Eggington S, Tsintzos S, Klein G. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation. Europace. 2014 May;16(5):652-9. doi: 10.1093/europace/eut380. Epub 2014 Jan 2.
Reynolds MR, Derdeyn CP, Grubb RL Jr, Powers WJ, Zipfel GJ. Extracranial-intracranial bypass for ischemic cerebrovascular disease: what have we learned from the Carotid Occlusion Surgery Study?. Neurosurg Focus. 2014 Jan;36(1):E9. doi: 10.3171/2013.10.FOCUS13427.
Van Calster B, Steyerberg EW, D’Agostino RB Sr, Pencina MJ. Sensitivity and specificity can change in opposite directions when new predictive markers are added to risk models. Med Decis Making. 2014 May;34(4):513-22. doi: 10.1177/0272989X13513654. Epub 2013 Dec 30.
van Diepen S, Brennan JM, Hafley GE, Reyes EM, Allen KB, Ferguson TB, Peterson ED, Williams JB, Gibson CM, Mack MJ, Kouchoukos NT, Alexander JH, Lopes RD. Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg. 2014 Aug;260(2):402-8. doi: 10.1097/SLA.0000000000000377.
Fowkes FG, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, Debacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D’Agostino RB Sr, Murabito JM, Norman P, Masaki KH, Bouter LM, Heine RJ, Stehouwer CD, McDermott MM, Stoffers HE, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco O, Hunink MG, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF; Ankle Brachial Index Collaboration. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol. 2014 Mar;21(3):310-20. doi: 10.1177/2047487313516564. Epub 2013 Dec 23.
Harskamp RE, Alexander JH, Schulte PJ, Jones WS, Williams JB, Mack MJ, Peterson ED, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, de Winter RJ, Lopes RD. Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. Ann Thorac Surg. 2014 Mar;97(3):824-30. doi: 10.1016/j.athoracsur.2013.09.099. Epub 2013 Dec 21.
Govindaraju DR, Pencina KM, Raj DS, Massaro JM, Carnes BA, D’Agostino RB. A systems analysis of age-related changes in some cardiac aging traits. Biogerontology. 2014 Apr;15(2):139-52. doi: 10.1007/s10522-013-9486-8. Epub 2013 Dec 14.
Hawkins BM, McCoy LA, Neely ML, Adusumalli S, Messenger JC, Drachman DE, Bass TA, O’Gara PT, Rao SV, Yeh RW. Impact of academic year timing on percutaneous coronary intervention outcomes at training institutions. J Am Coll Cardiol. 2014 Mar 18;63(10):1025-6. doi: 10.1016/j.jacc.2013.11.019. Epub 2013 Dec 11.
Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP; NCDR. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Mar 4;63(8):788-96. doi: 10.1016/j.jacc.2013.09.079. Epub 2013 Dec 11.
Matteau A, Yeh RW, Kereiakes D, Orav EJ, Massaro J, Steg PG, Normand SL, Cutlip DE, Mauri L. Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). Am J Cardiol. 2014 Apr 1;113(7):1146-52. doi: 10.1016/j.amjcard.2013.10.015. Epub 2013 Nov 8.
Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, McCabe EL, Coglianese EE, Amponsah M, Ho JE, Januzzi JL Jr, Wollert KC, Fradley MG, Vasan RS, Ellinor PT, Wang TJ, Benjamin EJ. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Am Heart J. 2014 Jan;167(1):109-115.e2. doi: 10.1016/j.ahj.2013.10.003. Epub 2013 Oct 17.
Bainey KR, Mehta SR, Lai T, Welsh RC. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J. 2014 Jan;167(1):1-14.e2. doi: 10.1016/j.ahj.2013.09.018. Epub 2013 Oct 16.
Murphy TP, Cooper CJ, Cutlip DE, Matsumoto A, Jamerson K, Rundback J, Rosenfield KA, Henrich W, Shapiro J, Massaro J, Yen CH, Burtch H, Thum C, Reid D, Dworkin L. Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study. J Vasc Interv Radiol. 2014 Apr;25(4):511-20. doi: 10.1016/j.jvir.2013.09.018. Epub 2013 Dec 8.
Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar;49(3):434-9. doi: 10.1038/bmt.2013.192. Epub 2013 Dec 9.
Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014 Mar 4;63(8):778-85. doi: 10.1016/j.jacc.2013.09.072. Epub 2013 Dec 4.
Motiwala SR, Szymonifka J, Belcher A, Weiner RB, Baggish AL, Gaggin HK, Bhardwaj A, Januzzi JL Jr. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res. 2014 Mar;7(2):250-61. doi: 10.1007/s12265-013-9522-8. Epub 2013 Dec 6.
Wallentin L, Becker RC, Cannon CP, Held C, Himmelmann A, Husted S, James SK, Katus HS, Mahaffey KW, Pieper KS, Storey RF, Steg PG, Harrington RA. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. Int J Cardiol. 2014 Jan 1;170(3):e59-62. doi: 10.1016/j.ijcard.2013.11.003. Epub 2013 Nov 13.
Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. doi: 10.1016/j.jacc.2013.10.058. Epub 2013 Nov 27.
Ky B, Putt M, Sawaya H, French B, Januzzi JL Jr, Sebag IA, Plana JC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014 Mar 4;63(8):809-16. doi: 10.1016/j.jacc.2013.10.061. Epub 2013 Nov 27.
Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014 Mar 4;63(8):747-62. doi: 10.1016/j.jacc.2013.09.070. Epub 2013 Nov 27.
Nunes MC, Tan TC, Elmariah S, do Lago R, Margey R, Cruz-Gonzalez I, Zheng H, Handschumacher MD, Inglessis I, Palacios IF, Weyman AE, Hung J. The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty. Circulation. 2014 Feb 25;129(8):886-95. doi: 10.1161/CIRCULATIONAHA.113.001252. Epub 2013 Nov 26.
Kohli P, Steg PG, Cannon CP, Smith SC Jr, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL; REACH Registry Investigators. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. Am J Med. 2014 Jan;127(1):53-60.e1. doi: 10.1016/j.amjmed.2013.08.017. Epub 2013 Nov 23.
Tremmel JA, Patel RA, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013. Catheter Cardiovasc Interv. 2014 May 1;83(6):936-43. doi: 10.1002/ccd.25301.
Chiang A, Gada H, Kodali SK, Lee MS, Jeremias A, Pinto DS, Bangalore S, Yeh RW, Henry TD, Lopez-Cruz G, Mehran R, Kirtane AJ. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv. 2014 Apr 1;83(5):721-6. doi: 10.1002/ccd.25276. Epub 2013 Nov 25.
Motiwala SR, Sarma A, Januzzi JL, O’Donoghue ML. Biomarkers in ACS and heart failure: should men and women be interpreted differently?. Clin Chem. 2014 Jan;60(1):35-43. doi: 10.1373/clinchem.2013.202531. Epub 2013 Nov 19.
Yeh RW, Vasaiwala S, Forman DE, Silbaugh TS, Zelevinski K, Lovett A, Normand SL, Mauri L. Instrumental variable analysis to compare effectiveness of stents in the extremely elderly. Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):118-24. doi: 10.1161/CIRCOUTCOMES.113.000476. Epub 2013 Nov 19.
Reynolds MR, Kamath AA, Grubb RL, Powers WJ, Adams HP, Derdeyn CP; Carotid Occlusion Surgery Study Investigators. The safety of aeroplane travel in patients with symptomatic carotid occlusion. J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):435-7. doi: 10.1136/jnnp-2013-306627. Epub 2013 Nov 18.
McCabe JM, Kennedy KF, Eisenhauer AC, Waldman HM, Mort EA, Pomerantsev E, Resnic FS, Yeh RW. Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs. Circulation. 2014 Jan 14;129(2):194-202. doi: 10.1161/CIRCULATIONAHA.113.006165. Epub 2013 Nov 18.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D’Agostino RB Sr, Dworkin LD; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005. Epub 2013 Nov 12.
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
Troughton R, Michael Felker G, Januzzi JL Jr. Natriuretic peptide-guided heart failure management. Eur Heart J. 2014 Jan;35(1):16-24. doi: 10.1093/eurheartj/eht463. Epub 2013 Nov 11.
Reynolds MR. Cardioversion with novel oral anticoagulants: reconfirming a 50-year-old standard. J Am Coll Cardiol. 2014 Mar 25;63(11):1088-9. doi: 10.1016/j.jacc.2013.10.037. Epub 2013 Nov 6.
Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D’Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol. 2014 Jan 1;113(1):117-22. doi: 10.1016/j.amjcard.2013.09.028. Epub 2013 Oct 4.
Gotto AM Jr, Cannon CP, Li XS, Vaidya S, Kher U, Brinton EA, Davidson M, Moon JE, Shah S, Dansky HM, Mitchel Y, Barter P; DEFINE Investigators. Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease. Am J Cardiol. 2014 Jan 1;113(1):76-83. doi: 10.1016/j.amjcard.2013.08.041. Epub 2013 Oct 4.
Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol. 2014 Jul 15;64(2):182-92. doi: 10.1016/j.jacc.2013.10.021. Epub 2013 Oct 31.
Généreux P, Stone GW, Harrington RA, Gibson CM, Steg PG, Brener SJ, Angiolillo DJ, Price MJ, Prats J, LaSalle L, Liu T, Todd M, Skerjanec S, Hamm CW, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators. Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). J Am Coll Cardiol. 2014 Feb 25;63(7):619-629. doi: 10.1016/j.jacc.2013.10.022. Epub 2013 Oct 30.
Cohen MG, Ghatak A, Kleiman NS, Naidu SS, Massaro JM, Kirtane AJ, Moses J, Magnus Ohman E, Džavík V, Palacios IF, Heldman AW, Popma JJ, O’Neill WW. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1057-64. doi: 10.1002/ccd.25277. Epub 2013 Nov 18.
Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2014 Jan 21;129(3):293-303. doi: 10.1161/CIRCULATIONAHA.113.004420. Epub 2013 Oct 29.
Stolker JM, Allen DS, Cohen DJ, Kennedy KF, Laster SB, Frutkin AD, Mehta SK, O’Neal KR, Marso SP. Comparison of procedural complications with versus without interventional cardiology fellows-in-training during contemporary percutaneous coronary intervention. Am J Cardiol. 2014 Jan 1;113(1):44-8. doi: 10.1016/j.amjcard.2013.08.037. Epub 2013 Oct 2.
Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, Fontana GP, Bavaria JE, Thourani VH, Herrmann HC, Pichard A, Kapadia S, Babaliaros V, Whisenant BK, Kodali SK, Williams M, Trento A, Smith CR, Teirstein PS, Cohen MG, Xu K, Tuzcu EM, Webb JG, Leon MB. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014 Mar 11;63(9):901-11. doi: 10.1016/j.jacc.2013.08.1641. Epub 2013 Oct 23.
O’Donoghue ML, Morrow DA, Tsimikas S, Sloan S, Ren AF, Hoffman EB, Desai NR, Solomon SD, Domanski M, Arai K, Chiuve SE, Cannon CP, Sacks FM, Sabatine MS. Lipoprotein(a) for risk assessment in patients with established coronary artery disease. J Am Coll Cardiol. 2014 Feb 18;63(6):520-7. doi: 10.1016/j.jacc.2013.09.042. Epub 2013 Oct 23.
Kohli P, Udell JA, Murphy SA, Cannon CP, Antman EM, Braunwald E, Wiviott SD. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). J Am Coll Cardiol. 2014 Jan 28;63(3):225-32. doi: 10.1016/j.jacc.2013.09.023. Epub 2013 Oct 16.
Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2014 Mar;68(3):314-29. doi: 10.1111/ijcp.12319. Epub 2013 Oct 15.
Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, Åsenblad N, Wallentin L. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets. 2014;25(7):517-25. doi: 10.3109/09537104.2013.842965. Epub 2013 Oct 15.
Reid KF, Pasha E, Doros G, Clark DJ, Patten C, Phillips EM, Frontera WR, Fielding RA. Longitudinal decline of lower extremity muscle power in healthy and mobility-limited older adults: influence of muscle mass, strength, composition, neuromuscular activation and single fiber contractile properties. Eur J Appl Physiol. 2014 Jan;114(1):29-39. doi: 10.1007/s00421-013-2728-2.
Margheri G, D’Agostino R, Trigari S, Sottini S, Del Rosso M. The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition. Lipids. 2014 Feb;49(2):203-6. doi: 10.1007/s11745-013-3845-8.
Januzzi JL Jr, van Kimmenade RR. Importance of rigorous evaluation in comparative biomarker studies. J Am Coll Cardiol. 2014 Jan 21;63(2):167-9. doi: 10.1016/j.jacc.2013.09.005. Epub 2013 Sep 24.
Selker HP, Oye KA, Eichler HG, Stockbridge NL, Mehta CR, Kaitin KI, McElwee NE, Honig PK, Erban JK, D’Agostino RB. A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials. Clin Pharmacol Ther. 2014 Feb;95(2):147-53. doi: 10.1038/clpt.2013.177. Epub 2013 Sep 23.
Hassan S, Karpova Y, Flores A, D’Agostino R Jr, Danhauer SC, Hemal A, Kulik G. A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies. Int Urol Nephrol. 2014 Mar;46(3):505-10. doi: 10.1007/s11255-013-0513-0. Epub 2013 Sep 21.
Sanidas EA, Brener SJ, Maehara A, Généreux P, Witzenbichler B, El-Omar M, Fahy M, Mehran R, Gibson CM, Stone GW. Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheter Cardiovasc Interv. 2014 Apr 1;83(5):704-10. doi: 10.1002/ccd.25203. Epub 2013 Oct 23.
Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, Cutlip DE, Mauri L, Yeh RW. Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. Catheter Cardiovasc Interv. 2014 May 1;83(6):975-83. doi: 10.1002/ccd.25179. Epub 2014 Jan 31.
Tan TW, Eslami MH, Kalish JA, Eberhardt RT, Doros G, Goodney PP, Cronenwett JL, Farber A; Vascular Study Group of New England. The need for treatment of hemodynamic instability following carotid endarterectomy is associated with increased perioperative and 1-year morbidity and mortality. J Vasc Surg. 2014 Jan;59(1):16-24.e1-2. doi: 10.1016/j.jvs.2013.07.025. Epub 2013 Aug 30.
Ghosh S, Ucer KB, D’Agostino R Jr, Grant K, Sirintrapun J, Thomas MJ, Hantgan R, Bharadwaj M, Gmeiner WH. Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity. Nanomedicine. 2014 Feb;10(2):451-61. doi: 10.1016/j.nano.2013.07.019. Epub 2013 Aug 27.
Liu CK, Lyass A, Massaro JM, D’Agostino RB Sr, Fox CS, Murabito JM. Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):301-7. doi: 10.1093/gerona/glt096. Epub 2013 Aug 2.
Geller BJ, Mega JL, Morrow DA, Guo J, Hoffman EB, Gibson CM, Ruff CT. Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial. J Thromb Thrombolysis. 2014 Apr;37(3):310-6. doi: 10.1007/s11239-013-0968-y.
Fox CS, Pencina MJ, Heard-Costa NL, Shrader P, Jaquish C, O’Donnell CJ, Vasan RS, Cupples LA, D’Agostino RB. Trends in the association of parental history of obesity over 60 years. Obesity (Silver Spring). 2014 Mar;22(3):919-24. doi: 10.1002/oby.20564. Epub 2014 Feb 6.
Giri J, Yeh RW, Kennedy KF, Hawkins BM, Weinberg I, Weinberg MD, Parikh SA, Garasic J, Jaff MR, White CJ, Rosenfield K. Unprotected carotid artery stenting in modern practice. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):595-602. doi: 10.1002/ccd.25090. Epub 2013 Nov 15.
Geltman PL, Hunter Adams J, Penrose KL, Cochran J, Rybin D, Doros G, Henshaw M, Paasche-Orlow M. Health literacy, acculturation, and the use of preventive oral health care by Somali refugees living in massachusetts. J Immigr Minor Health. 2014 Aug;16(4):622-30. doi: 10.1007/s10903-013-9846-0.
Sales KU, Giudice FS, Castilho RM, Salles FT, Squarize CH, Abrahao AC, Pinto DS Jr. Cyclin D1-induced proliferation is independent of beta-catenin in head and neck cancer. Oral Dis. 2014 Apr;20(3):e42-8. doi: 10.1111/odi.12124. Epub 2013 Jun 4.
De Luca G, van’t Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Secco GG, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Dudek D. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. Heart Vessels. 2014 Jan;29(1):15-20. doi: 10.1007/s00380-013-0323-4. Epub 2013 Mar 14.
Choi JS, Kim EY, Kim MJ, Khan FA, Giegengack M, D’Agostino R Jr, Criswell T, Khang G, Soker S. Factors affecting successful isolation of human corneal endothelial cells for clinical use. Cell Transplant. 2014;23(7):845-54. doi: 10.3727/096368913X664559. Epub 2013 Feb 26.
Celik T, Kaya MG, Akpek M, Yarlioglues M, Sarli B, Topsakal R, Gibson CM. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology. 2014 Mar;65(3):198-204. doi: 10.1177/0003319712474948. Epub 2013 Jan 31.
Reynolds MR, Lane AN, Robertson B, Kemp S, Liu Y, Hill BG, Dean DC, Clem BF. Control of glutamine metabolism by the tumor suppressor Rb. Oncogene. 2014 Jan 30;33(5):556-66. doi: 10.1038/onc.2012.635. Epub 2013 Jan 28.
Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Am J Ther. 2014 Nov-Dec;21(6):500-8. doi: 10.1097/MJT.0b013e31826fc43c.
Kumar S, Doughty C, Doros G, Selim M, Lahoti S, Gokhale S, Schlaug G. Recovery of swallowing after dysphagic stroke: an analysis of prognostic factors. J Stroke Cerebrovasc Dis. 2014 Jan;23(1):56-62. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.005. Epub 2012 Oct 24.
Niileksela CR, Reynolds MR. Global, broad, or specific cognitive differences? Using a MIMIC model to examine differences in CHC abilities in children with learning disabilities. J Learn Disabil. 2014 May-Jun;47(3):224-36. doi: 10.1177/0022219412453172. Epub 2012 Aug 18.